BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33914050)

  • 21. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    Kim JJ; Burger EA; Sy S; Campos NG
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
    Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
    JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recall Efforts Successfully Increase Follow-Up for Cervical Cancer Screening Among Women With Human Papillomavirus in Honduras.
    Thomson KA; Sandoval M; Bain C; Holme F; Bansil P; Figueroa J; de Sanjosé S
    Glob Health Sci Pract; 2020 Jun; 8(2):290-299. PubMed ID: 32606095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
    Mills JM; Morgan JR; Dhaliwal A; Perkins RB
    Gynecol Oncol; 2021 Aug; 162(2):308-314. PubMed ID: 34090706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
    Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.
    Phelan DF; Boitnott JK; Clark DP; Dubay LC; Gravitt PE
    Obstet Gynecol; 2011 Aug; 118(2 Pt 1):289-295. PubMed ID: 21775844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.
    Granados R; Tellez-Safina H; Solis I; Mateos F; Rodriguez-Barbero JM; Aramburu JA; Huertas MA; Bajo P; Camarmo E; Corrales T; Medina P; Calvo B; Martin E; Anta L; Zamora M; Alcaide T
    Diagn Cytopathol; 2017 Dec; 45(12):1065-1072. PubMed ID: 28949442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to Cervical Cancer Screening Guidelines Among Women Aged 66-68 Years in a Large Community-Based Practice.
    Chao CR; Xu L; Lonky NM
    Am J Prev Med; 2019 Dec; 57(6):757-764. PubMed ID: 31753257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer screening in the era of human papillomavirus testing and vaccination.
    Murphy J; Mark H
    J Midwifery Womens Health; 2012; 57(6):569-576. PubMed ID: 23050698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
    Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
    J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.
    Zorzi M; Frayle H; Rizzi M; Fedato C; Rugge M; Penon MG; Bertazzo A; Callegaro S; Campagnolo M; Ortu F; Del Mistro A;
    BJOG; 2017 Sep; 124(10):1585-1593. PubMed ID: 28120382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
    Luque JS; Tarasenko YN; Chen C
    J Prim Prev; 2018 Aug; 39(4):329-344. PubMed ID: 29876723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Human Papillomavirus Test Uptake and Cervical Cancer Screening Trends in the Midwest, United States.
    Ehman KM; Jenkins GD; Grimm JA; Cammack TL; Samuelson BJ; Stoll RJ; Maxson JA; MacLaughlin KL
    J Prim Care Community Health; 2024; 15():21501319241251934. PubMed ID: 38726652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.
    Rustagi AS; Kamineni A; Weiss NS
    Am J Epidemiol; 2013 Oct; 178(7):1020-2. PubMed ID: 23966563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
    Parekh N; Donohue JM; Men A; Corbelli J; Jarlenski M
    Obstet Gynecol; 2017 Jan; 129(1):66-75. PubMed ID: 27926644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
    Zhang D; Advani S; Huchko M; Braithwaite D
    BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.